SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mark L. Urken, Mira Milas, Gregory W. Randolph, Ralph Tufano, Donald Bergman, Victor Bernet, Elise M. Brett, James D. Brierley, Rhoda Cobin, Gerard Doherty, Joshua Klopper, Stephanie Lee, Josef Machac, Jeffrey I. Mechanick, Lisa A. Orloff, Douglas Ross, Robert C. Smallridge, David J Terris, Jason B Clain, Michael Tuttle, Management of recurrent and persistent metastatic lymph nodes in well-differentiated thyroid cancer: A multifactorial decision-making guide for the thyroid cancer care collaborative, Head & Neck, 2015, 37, 1
  2. 2
    Aarti Mathur, Martha A. Zeiger, Genomic medicine for cancer prognosis, Journal of Surgical Oncology, 2014, 110, 8
  3. You have free access to this content3
    Petros Perros, Kristien Boelaert, Steve Colley, Carol Evans, Rhodri M Evans, Georgina Gerrard BA, Jackie Gilbert, Barney Harrison, Sarah J Johnson, Thomas E Giles, Laura Moss, Val Lewington, Kate Newbold, Judith Taylor, Rajesh V Thakker, John Watkinson, Graham R. Williams, Guidelines for the management of thyroid cancer, Clinical Endocrinology, 2014, 81,
  4. 4
    Hetal H. Patel, Neerav Goyal, David Goldenberg, Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer, Annals of Medicine, 2014, 46, 6, 409

    CrossRef

  5. 5
    Ralph P. Tufano, Gary Clayman, Keith S. Heller, William B. Inabnet, Electron Kebebew, Ashok Shaha, David L. Steward, R. Michael Tuttle, Management of Recurrent/Persistent Nodal Disease in Patients with Differentiated Thyroid Cancer: A Critical Review of the Risks and Benefits of Surgical Intervention Versus Active Surveillance, Thyroid, 2014, 141020123104000

    CrossRef

  6. 6
    Celestino Pio Lombardi, Marco Raffaelli, Carmela De Crea, Luca Sessa, Rocco Bellantone, Morbidity of central neck dissection: primary surgery vs reoperation. Results of a case–control study, Langenbeck's Archives of Surgery, 2014, 399, 6, 747

    CrossRef

  7. 7
    Maria Papaleontiou, Megan R. Haymart, New insights in risk stratification of differentiated thyroid cancer, Current Opinion in Oncology, 2014, 26, 1, 1

    CrossRef

  8. 8
    Douglas S. Ross, R. Michael Tuttle, Observing Micopapillary Thyroid Cancers, Thyroid, 2014, 24, 1, 3

    CrossRef

  9. 9
    Paula Soares, Ricardo Celestino, Miguel Melo, Elsa Fonseca, Manuel Sobrinho-Simões, Prognostic biomarkers in thyroid cancer, Virchows Archiv, 2014, 464, 3, 333

    CrossRef

  10. 10
    Edwin O. Onkendi, Travis J. McKenzie, Melanie L. Richards, David R. Farley, Geoffrey B. Thompson, Jan L. Kasperbauer, Ian D. Hay, Clive S. Grant, Reoperative Experience with Papillary Thyroid Cancer, World Journal of Surgery, 2014, 38, 3, 645

    CrossRef

  11. 11
    Glenda G. Callender, Tobias Carling, Emily Christison-Lagay, Robert Udelsman, Surgery for Thyroid Cancer, Endocrinology and Metabolism Clinics of North America, 2014, 43, 2, 443

    CrossRef

  12. 12
    Daniele Barbaro, Roberto Mario Incensati, Gabriele Materazzi, Giuseppe Boni, Mariano Grosso, Erica Panicucci, Paola Lapi, Cristina Pasquini, Paolo Miccoli, The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis, Endocrine, 2014, 45, 3, 462

    CrossRef

  13. 13
    Malgorzata Wierzbicka, Edyta Gurgul, Elżbieta Wasniewska-Okupniak, Maria Gryczynska, Tomasz Piorunek, Marek Ruchala, The feasibility and efficacy of secondary neck dissections in thyroid cancer metastases, European Archives of Oto-Rhino-Laryngology, 2014, 271, 4, 795

    CrossRef

  14. 14
    Ozan B. Ozgursoy, David W. Eisele, Ralph P. Tufano, The Prognostic Implications from Molecular Testing of Thyroid Cancer, Otolaryngologic Clinics of North America, 2014, 47, 4, 595

    CrossRef

  15. 15
    Amir H. Lebastchi, Glenda G. Callender, Thyroid cancer, Current Problems in Cancer, 2014, 38, 2, 48

    CrossRef

  16. 16
    Robert L. Witt, Robert L. Ferris, Edmund A. Pribitkin, Steven I. Sherman, David L. Steward, Yuri E. Nikiforov, Diagnosis and management of differentiated thyroid cancer using molecular biology, The Laryngoscope, 2013, 123, 4
  17. 17
    Kevin E. Fisher, Jigna C. Jani, Sarah B. Fisher, Cora Foulks, Charles E. Hill, Collin J. Weber, Cynthia Cohen, Jyotirmay Sharma, Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma, Journal of Surgical Research, 2013, 185, 1, 217

    CrossRef

  18. 18
    Mingzhao Xing, Bryan R Haugen, Martin Schlumberger, Progress in molecular-based management of differentiated thyroid cancer, The Lancet, 2013, 381, 9871, 1058

    CrossRef

  19. 19
    Sun Choi, HeonSoo Park, Myung Kang, Dong Lee, Kang Lee, Hyoung Lee, Sung Kim, Eun Lee, Jong Hong, The relationship between the BRAFV600E mutation in papillary thyroid microcarcinoma and clinicopathologic factors, World Journal of Surgical Oncology, 2013, 11, 1, 291

    CrossRef